Mountain View, California (PressExposure) October 01, 2009 -- With a struggling economy, rising drug costs and an aging population using more prescription medicines, the need for inspection to differentiate counterfeit pharmaceuticals from authentic drugs has never been more important. Imitation drugs currently cost pharmaceutical companies an estimated $46 billion annually and carry a burden of liability and damaged reputations. Of greater concern, however, is the global risk to health and the rising death rate from ingested counterfeit medicines.
Recent advances in the field of X-ray diffraction now make it possible to introduce XRD analysis as a portable inspection tool for the purpose of phase identification and quantification of counterfeit pharmaceuticals.
Assisting various worldwide government agencies in their drive to combat the trafficking of fraudulent medications, inXitu is pleased to introduce a tailored version of its field portable XRD analyzer, TERRA.
Completely contained and ready for operation in remote environments and at all points along the global pharmaceutical supply chain, TERRA is well suited to the rapid determination of illegally manufactured medicines. In as little as two minutes TERRA can perform qualitative and quantitative XRD analysis to validate pharmaceutical authenticity. An application report is available on request.